RecallDepth
Class II Ongoing

Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intrathecal use, Mfd. in India for Auromedics Pharma LLC., E Windsor, NJ, 08520, NDC 55150-385-01.

This recall is currently active, issued October 11, 2023. It was issued by Eugia Us Llc.

Company
Eugia Us Llc
Recall Initiated
September 28, 2023
Posted
October 11, 2023
Recall Number
D-0041-2024
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
1,626 vials
Firm Location
East Windsor, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: 3TC22010, Exp 11/30/2024

More recalls by Eugia Us Llc

View all recalls by this company →

Other recent Class II Drug recalls